Mirko Ancillotti is a post-doc researcher at CRB. His research areas are public health and applied ethics and his interests include health preference research. His background is in philosophy, which he studied at the University of Valencia, Spain, and at the University of Pisa, Italy, where he earned a master of arts in 2012. His master thesis covered John Harris’ influence on contemporary bioethical debate on cloning and enhancement. In 2021, he earned his PhD in medical sciences from Uppsala University, and the Centre for Research Ethics & Bioethics, where he started working in September 2013. From 2014 to 2015, he worked on a research project on public understanding and media portrayal of synthetic biology before starting his PhD project on antibiotic resistance and the role of individual responsibility and behaviour.
He is currently involved in the EU projects ENLIGHTENme and OncoLogics. ENLIGHTENme studies how urban lighting affects the population's health and well-being. Together with Deborah Mascalzoni, Mirko Ancillotti works on the ethical aspects of the project, considering also the effects of light pollution on other life forms. OncoLogics aims at creating a platform for personalised colorectal cancer clinical therapy decision support. Together with CRB colleagues Deborah Mascalzoni, Åsa Grauman, and Jorien Veldwijk, Mirko Ancillotti studies the medical ethics aspects of the project and works on the elucidation and integration of patients’ preferences in the development of the decision support platform.
Recently in the media
- Mirko Ancillotti & bioethics. Resistance to antibiotics vs. vaccines.
The AMR Studio, 2021-03-01
- Mirko Ancillotti & public awareness of antibiotic resistance.
The AMR Studio, 2019-03-12
Mirko Ancillotti is looking at antibiotics resistance and the ethical aspects of using peptide-based antibiotics.
Codex - Rules and guidelines for research
CODEX is your gateway to various research ethics guidelines. It is run from Uppsala University's Centre for Research Ethics & Bioethics.
Media portrayal of synthetic biology
Does It Matter How You Ask?: Assessing the Impact of Failure or Effectiveness Framing on Preferences for Antibiotic Treatments in a Discrete Choice Experiment
Part of Patient Preference and Adherence, p. 2921-2936, 2022.
Part of Bioethics, p. 3-9, 2022.
Part of Humanities and Social Sciences Communications, 2022.
Part of Value in Health, p. 2044-2052, 2022.
Socio-cultural determinants of antibiotic resistance: a qualitative study of Greeks’ attitudes, perceptions and values
Part of BMC Public Health, 2022.
Part of Frontiers in Sustainable Food Systems, 2022.
Part of Public Health Ethics, p. 1-11, 2021.
Antibiotic Resistance: A Multimethod Investigation of Individual Responsibility and Behaviour
Part of Managing Antimicrobial Resistance Through Behaviour Change, p. 16-19, 2021.
Part of Managing Antimicrobial Resistance Through Behavior Change, March 2021, p. 13-14, 2021.
Synthetic biology, ethics and antibiotics
Who shapes public opinion of science? How do people make trade-offs between risks and benefits of technology that could both help and harm? Mirko Ancillotti is moving from media portrayal of synthetic biology to antibiotic resistance and the ethical aspects of using a new kind of peptide-based antibiotics.